Futura Medical – Eroxon Awarded “New Product of the Year, Healthcare” by Boots
Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), the pharmaceutical company developing innovative sexual health products, announces that Eroxon® has won the “New Product of the Year, Healthcare” category at the Boots Supplier Awards 2023, following its UK launch earlier this year. The award is further recognition for Futura’s breakthrough treatment for erectile dysfunction (“ED”) as it provides an alternative treatment option for the 4.3 million men in the UK experiencing symptoms*.
*Figures based on men reporting occasional and frequent difficulty getting or maintaining an erection, ref Kantar TNS Omnibus Survey Dec 2010 in a survey of 1,033 men. Stats are UK unless stated otherwise.
